Name : Tafazzin Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN1579369880
| Long name | Tafazzin Primary Polyclonal Antibody |
| Also known as | Tafazzin PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | Tafazzin |
| Specificity | This is a highly specific antibody against Tafazzin |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Tafazzin |
| Gene ID number | 6901 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | A long form and a short form of each of these isoforms is produced, Multiple transcript variants encoding different isoforms have been described, Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known, and left ventricular noncompaction (LVNC), dilated cardiomyopathy (DCM), endocardial fibroelastosis, hypertrophic DCM, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound, This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | Cardiomyopathy dilated 3A X linked, EFE2, Endocardial fibroelastosis 2, Protein G4, TAZ, TAZ protein, TAZ protein, TAZ_HUMAN, Tafazzin, 5, Barth syndrome |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | Tafazzin |
| Short name | Tafazzin Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | Tafazzin (Antibody to) |
| Alternative technique | antibodies |
| Identity | 11577 |
| Gene | TAZ |
| Long gene name | tafazzin |
| Synonyms gene | CMD3A EFE2 EFE |
| Synonyms gene name | dilated 3A (X-linked) , endocardial fibroelastosis 2 cardiomyopathy |
| Synonyms | BTHS XAP-2 G4, 5 TAZ1 |
| Synonyms name | Barth syndrome |
| Locus | Xq28 |
| Discovery year | 1989-05-29 |
| GenBank acession | X92762 |
| Entrez gene record | 6901 |
| Pubmed identfication | 8042670 |
| Havana BLAST/BLAT | OTTHUMG00000033190 |
| Locus Specific Databases | TAZbase: Mutation registry for Barth syndrome LRG_131 |